# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-25-107416
Filing Date
2025-08-12
Accepted
2025-08-12 16:45:30
Documents
16
Period of Report
2025-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | hrtx-20250808.htm iXBRL | 8-K | 94137
2 | EX-3.1 | hrtx-ex3_1.htm | EX-3.1 | 127164
3 | EX-10.1 | hrtx-ex10_1.htm | EX-10.1 | 139571
4 | EX-10.2 | hrtx-ex10_2.htm | EX-10.2 | 773845
5 | EX-10.3 | hrtx-ex10_3.htm | EX-10.3 | 333254
6 | EX-10.4 | hrtx-ex10_4.htm | EX-10.4 | 747364
7 | EX-10.5 | hrtx-ex10_5.htm | EX-10.5 | 751002
| Complete submission text file | 0000950170-25-107416.txt |  | 3525515

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | hrtx-20250808.xsd | EX-101.SCH | 51192
18 | EXTRACTED XBRL INSTANCE DOCUMENT | hrtx-20250808_htm.xml | XML | 4892

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 251207487
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)